After the European Medicines Agency (EMA) approves a new cancer drug, reimbursement decisions by each country’s health authorities can take up to one year, with wide variations between countries. according to a study just presented [more]
«Better quality, innovative healthcare for the benefit of patients, especially those with unmet medical needs» this is the main goal of the proposal for strenghtening cooperation within the European Union on the assessment of health [more]
With health budgets flat-lining and demand for healthcare rising, the only way Europe can improve patient outcomes is by finding new ways to do things better. But who will champion innovation in cancer care and [more]